The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

Embodiments herein relate to reflective optical medical sensor devices. In an embodiment, a reflective optical medical sensor device including a central optical detector and a plurality of light emitter units disposed around the central optical detector is provided. A plurality of peripheral optical detectors can be disposed to the outside of the plurality of light emitter units. Each of the plurality of peripheral optical detectors can form a channel pair with one of the plurality of light emitter units. The reflective optical medical sensor device can also include a controller in electrical communication with the central optical detector, the light emitter units, and the peripheral optical detectors. The controller can be configured to measure performance of channel pairs; select a particular channel pair; and measure a physiological parameter using the selected channel pair. Other embodiments are also included herein.

The present invention discloses a capsule device for pressure measurement. The capsule device comprises a capsule enclosure, a data transmission assembly and a thin film pressure sensor. The capsule enclosure is formed with an accommodating chamber, and the data transmission assembly is arranged in the accommodating chamber. The thin film pressure sensor is attached to the outer surface of the capsule enclosure to measure pressure, and the thin film pressure sensor is connected with the data transmission assembly.

A laser device includes a seed laser, a plurality of optical amplifiers, and an optical distribution assembly. The seed laser is configured to emit seed laser light. The plurality of optical amplifiers is configured to generate amplified laser light by amplifying the seed laser light. The optical distribution assembly is configured to distribute the seed laser light to an input of each of the optical amplifiers in the plurality and each of the optical amplifiers is configured to direct its respective amplified laser light to a common target.

Provided in the present disclosure are an electrical impedance tomography based method and device for generating a three-dimensional blood perfusion image. The method (100) comprises: using an electrode array distributed in a three-dimensional space to perform electrical impedance measurement on a human body region to be measured so as to obtain an electrical impedance measurement signal (110); and on the basis of a blood perfusion signal in the electrical impedance measurement signal, reconstructing a three-dimensional blood perfusion image by means of an image reconstruction algorithm (120). Therefore, a three-dimensional image of electrical impedance variations caused by blood perfusion can be generated; and compared with a two-dimensional image in the prior art, the three-dimensional image can more intuitively reflect the blood perfusion condition of a volume area in the three-dimensional space of a human body region, and facilitates image analysis and comparison and disease detection and diagnosis.

An electroencephalography net (44) comprised of electrodes (34, 36) coupled together by a connector (28) comprising separate elastically (32) and plastically (30) deformable elements.

The present invention provides a device for non-invasive monitoring and/or detection of diabetes in a subject based on detection of volatile organic compounds (VOCs) in the exhaled breath of a subject. The device comprises a functionalized carbon nanotube-based array sensor which can reversibly bind VOCs, which alters the electrical conductivity of the sensor array, which can be interpreted to monitor and/or diagnose diabetes.

A medical device may include a lower housing, a printed circuit board (PCB) received within the lower housing, a top housing, two plungers received in gaps within the top housing, and strain gauges mounted to the PCB. The strain gauges may define two polygons aligned with the two plungers. The two plungers may be in contact with the strain gauges such that a force on a plunger is transferred to the strain gauges in contact with the respective plunger. The load magnitude and load location may be determined based on the measured strain of the strain gauges.

Disclosed herein is a pressure-relief mattress comprising: a plurality of inflatable bladders; a pressure sensor pad arranged to detect pressure exerted on a subject, the pressure sensor pad comprising a plurality of pressure sensor cells being arranged in a matrix with at least one row and at least one column; a pressure-sensing electronic unit electrically connected with the plurality of pressure sensor cells; and a pressure-control electronic unit communicatively connected with the pressure-sensing electronic unit; wherein the pressure-sensing electronic unit is configured for generating a measurement result indicative of a pressure exerted upon the subject at one or more of the pressure sensor cells, the pressure control electronic unit is configured for controlling operation of one or more of the inflatable bladders according to the pressure measurement result.

Methods, systems, and coaptation measurement devices as described herein include an elongate sensor body at the end of a proximal connecting member, and a plurality of sensors in an array across a face of the sensor body, wherein each sensor of the plurality of sensors is configured to detect if a portion of a heart valve is in contact with the sensor.